BJCM
PRAH

Blue Jay Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Blue Jay Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$7.99M Sell
106,555
-33,445
-24% -$2.32M 5.45% 7
2017
Q1 		$9.13M Buy
+140,000
New +$8.25M 4.49% 15

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Blue Jay Capital Management's PRAH Position: Q2 2017 in Review

Blue Jay Capital Management reduced its PRA Health Sciences, Inc. (PRAH) stake by 24% in Q2 2017, selling an estimated $2.32M and leaving 106,555 shares worth $7.99M. The position accounts for 5.45% of the portfolio, ranked #7.

Blue Jay Capital Management first reported a position in PRAH in Q1 2017 and has held it in 2 quarters since. The position peaked at $9.13M in Q1 2017. 236 funds tracked by Wall St. Rank hold PRAH as of Q2 2017.

  • Blue Jay Capital Management held 106,555 shares of PRA Health Sciences, Inc. worth $7.99M as of Q2 2017.
  • Blue Jay Capital Management sold 33,445 PRA Health Sciences, Inc. shares in Q2 2017, an estimated $2.32M.
  • PRA Health Sciences, Inc. made up 5.45% of Blue Jay Capital Management's portfolio in Q2 2017, its #7 holding.
  • Blue Jay Capital Management first reported a position in PRA Health Sciences, Inc. in Q1 2017 and has held it in 2 quarters since.
  • Blue Jay Capital Management's PRA Health Sciences, Inc. position peaked at $9.13M in Q1 2017.
  • 236 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2017.

Based on Blue Jay Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.